Skip to content

Clinical trials

Phase 3 Stroke trials in Lithuania

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Phase: Phase 3 Country / region: Lithuania Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20091
20111
20131
20141
20161
20171
20182
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC2
Novartis Pharmaceuticals2
CSL Behring1
Eli Lilly and Company1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Remedy Pharmaceuticals, Inc.1
Sanofi1
Takeda1
University College Dublin1
University Hospital of North Norway1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke12
Myocardial Infarction4
Atrial Fibrillation3
Cardiovascular Diseases3
Coronary Artery Disease3
Heart Failure3
Acute Coronary Syndrome2
Atherosclerosis2
Heart Diseases2
Ischemic Stroke2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.